Puncture site: Carotid stenting should be undertaken within an interventional (endovascular) program in which personnel are familiar with efficient and safe arterial sheath removal with minimal patient discomfort. Adequate hydration and pretreatment with atropine can prevent and treat hypotension associated with a vaso-vagal response to sheath removal. An unexplained decrease in blood pressure may be caused by retroperitoneal bleeding. Closure devices are recommended if used by trained personnel. Complications of closure devices could be disastrous (hematoma, infection, torn artery).
The occurrence of spasm in the distal internal carotid artery is a common angiographic event caused by the mechanical irritation of the vessel. It usually resolves spontaneously after the catheter or guide wire has been removed. Usage of 0.014-inch soft-tipped wires minimizes the occurrence of spasm. Injections of 100 to 200 mg of nitroglycerine through the carotid access sheath will hasten the resolution of spasm. Spasm must be differentiated from kinking of the internal carotid artery.
Bradycardia and episode of transient asystole are not uncommon during balloon inflations within the carotid bulbous. More prolonged hypotension and bradycardia were seen with balloon-expandable stents which place more sustained pressure on the baro-receptors. Both, bradycardia and asystole during balloon inflation are transient and respond promptly to balloon deflation. Prevention is pre-medication with atropine. Larger doses of atropine should be avoided in elderly patients. Hypotension is not uncommon after carotid stenting and may last from hours to days, depending on the sensitivity of the baroreceptors, the type of stent used, and whether CAS was performed bilaterally. The degree of hypotension appears to be more pronounced in heavily calcified lesions. Usually, there are no clinical sequelae and the modest decrease in blood pressure requires no specific intervention. Bed rest, sedation or narcotics exacerbate hypotension and mitigate against rapid ambulation and recovery. Patients, particularly the elderly, should be assisted with ambulation if
Complications and Events Encountered During Carotid Stenting

Minor Major
Puncture Site Carotid dissection Hematoma, retroperitoneal bleed Carotid perforation Carotid artery spasm Acute stent thrombosis Transient bradycardia
Major stroke Post-stenting hypotension Cerebral hemorrhage Re-perfusion syndrome Contrast encephalopathy Stenosis or occlusion of the external carotid artery Transient cerebral ischemia (intra-procedural) with ischemic seizure or loss of consciousness Transient ischemic attack (TIA), -amaurosis fugax Minor embolic stroke, prolonged amaurosis fugax there are additional postural effects. If necessary, standard pseudoephedrine tablets, 2 every 6 hours, will increase the blood pressure temporarily. All patients with hypotension should be well hydrated, have routine hemoglobin and hematocrit checks and have the groin examined. It is important that other important causes of hypotension such as retroperitoneal bleeding not be overlooked. Re-perfusion syndrome: In some hypertensive patients, and in patients with critical (>90%) lesions we have observed a transient postprocedural confusional state with headaches, occasionally associated with transient localizing symptoms, and not associated with angiographic abnormalities. A computed tomography (CT) or magnetic resonance scan will often show mild hemispheric swelling with effacement of sulci or suggest luxury perfusion. The symptoms usually resolves over 24 hours with good control of blood pressure. Contrast encephalopathy is a rare syndrome in which the ipsilateral hemisphere to the CAS was overloaded with contrast agent. Patients developed a profound neurological deficit associated with the hemisphere at risk. CT scan characteristically shows marked contrast staining in the basal ganglia and in the cortex. There are no angiographic abnormalities. Patients usually recover within 24 to 48 hours with good hydration and control of the blood pressure. Transient cerebral ischemia (TCI) is a syndrome of almost complete or complete deprivation of blood flow to the cerebral tissue at the time of occlusion of the carotid artery (isolated hemisphere) with the angioplasty balloon or balloon embolic protection device. Sudden loss of consciousness with ischemic pseudo-seizure and contralateral extremities weakness is common. It completely reverses on prompt balloon deflation and reestablishment of the blood flow. Same symptoms are seen in the presence of contralateral internal carotid artery occlusion in which the opposite hemisphere is supplied through the anterior communicating artery. In this situation the angioplasty balloon has to be inflated for the shortest period of time possible, both during the predilatation and eventual post-dilatation of the stent. In these anatomical situations occlusion embolic device is contraindicated. TIA (Transient ischemic attack) is an ischemic event with localizing neurological symptoms which usually resolves in minutes, but no later then in 24 hours. Transient amaurosis fugax should be counted as TIA. Minor stroke is a neurological deficit with increases the National Institutes of Health Stroke Scale (NIHSS) by £ 3 points, or deficit with complete resolution of neurological symptoms within 30 days. Prolonged amaurosis fugax with resolution in 30 day should be counted as minor stroke.
Major complications resulting in severe clinical sequelae are rare when carotid stenting is performed with meticulous technique and embolic protection. Technique dependent complications are carotid dissection and carotid perforation. They are usually clinically asymptomatic, but not necessarily. Carotid dissection is a significant complication of the procedure. The most serious dissection is the on in the ICA distal to the stent. Distal dissection may occur when attempting to stent a lesion that is adjacent to a severe distal kink or bend point, but can also develop when the post dilatation of the stent is performed across the distal end of the stent with high inflation pressure. Dissection can be also caused by trying to force stiff peripheral balloons or stiff-ended stent delivery systems through bend points while trying to position the balloon or stent in the lesion. Distal dissections are best treated by using flexible stents of appropriate size. As mentioned previously the protection occlusion balloon system can cause the ICA dissection as well. The second, less common site for dissection, is in the common carotid artery caused by the tip of the guiding sheath. This complication can be treated, if necessary, by using another stent in the common carotid artery.
Carotid perforation is extremely rare event Perforation can occurred by aggressive balloon sizing in a misguided attempt to optimize the luminal appearance of the stented. If the perforation occurs, the leakage of the contrast from the internal carotid artery can be sealed with prolonged soft balloon inflation after heparin is reversed with appropriate dose of protamine sulfate. Another stent or covered stent can be applied.
Stent thrombosis is uncommon in CAS. The low rate of stent thrombosis is predicated on correct and compulsive use of appropriate doses of adjunctive antiplatelet therapy. Basic stenting techniques must be followed. These include the following: (1) only stenting in the presence of brisk flow without significant inflow or outflow obstruction; (2) stenting from normal segment to normal segment if possible; and (3) ensuring proper stent sizing (oversizing in the case of self-expanding stents) and careful opposition to the vessel wall.
Distal embolization causing major ischemic stroke is the commonest serious complication of carotid stenting. Careful patient and lesion selection, meticulous technique and usage of the embolic protection devises minimize this complication. The potential causes of distal embolization are:
Causes of Major Distal Embolization
More Frequent -Predilatation with oversized peripheral balloon.
-Forcing stent across the lesion (especially heavily calcified).
-Postdilating aggressively and/or with an oversized balloon.
-Persistent, aggressive attempts to access a tortuous, highly atherosclerotic common carotid artery with the sheath. It is essential to monitor the neurological status after every step of the procedure 40 . Any changes in neurological status should prompt the operator to optimize the blood pressure and hydration and clarify the status of the cervical and intracranial vasculature. The change in neurological status may be a result of slow flow from lesion recoil, guide wire induced spasm, or dissection. The stenting procedure should be quickly and efficiently completed. If a change in neurological status does not resolve and there are no signs of embolism on intracranial angiography, a CT scan should be performed immediately to rule out intra-cerebral hemorrhage or re-perfusion syndrome. If intracranial embolus is detected, appropriate steps are taken to recanalize the occluded vessel as soon as possible.
Cerebral hemorrhage is a devastating, occasionally fatal complication of carotid stenting. Cerebral hemorrhage has been associated with at least one, but usually a combination, of the following factors: 1) CAS on preocclusive or occluded artery; 2) excessive anticoagulation; 3) poorly controlled hypertension; 4) stenting in the presence of a recent ischemic stroke (< 3 weeks); and 5) presence of a vulnerable aneurysm. Anticoagulation should be monitored carefully with use of ACT measurements, which should not exceed 200 to 250 seconds. Control of hypertension is very important, especially in elderly patients and after stenting a pre-occlusive stenosis. If a cerebral hemorrhage is suspected, the procedure should be terminated. Anticoagulation should be reversed with protamine sulfate (if possible), and an emergency CT scan should be performed. Sudden loss of consciousness preceded by a headache in the absence of intracranial vessel occlusion and presence of moderate mass effect should alert the operator to this devastating event.
J.J. Vitek, M.D. Lenox Hill Heart and Vascular Institute of New York Black Hall 9 th FI 130 East, 77 th Street New York, N.Y. 10021-1803 USA
